ReShape Lifesciences to Participate in Investor Conferences in March
March 15-17: Oppenheimer 32nd Annual Virtual Healthcare Conference. Bart Bandy, Chief Executive Officer and President, and Tom Stankovich, Chief Financial Officer, will present a Company overview on Wednesday, March 16, at 2:00 pm ET. A live webcast of the presentation will be available on the “Events and Presentations” section of ReShape’s website at: https://ir.reshapelifesciences.com/events-and-presentations. An archived replay will be available on the company’s website for a period of 90 days after the conference. March 28-29: Maxim 2nd Annual Virtual Growth Conference. Mr. Bandywill participate in a fireside chat on Monday, March 28, at 4:30 pm ET. Interested parties can register to attend the conference via the link here.
ReShape’s management team will be available for one-on-one meetings during both conferences. To schedule a one-on-one meeting, please contact your respective conference representative or
ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the
Chief Financial Officer
Investor Relations Contact:
Source: ReShape Lifesciences Inc